PSYC (PSYC) Total Receivables: $0.24 Mil (As of Jun. 2017)


What is PSYC Total Receivables?

PSYC PSYC -99.00% Total Receivables is $0.24 Mil as of Jun. 2017.

PSYC's Total Receivables for the quarter that ended in Jun. 2017 was $0.24 Mil.

PSYC Total Receivables Historical Data

* Premium members only.

The historical data trend for PSYC's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PSYC Total Receivables Chart

PSYC Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec16
Total Receivables
0.01 0.01 0.02 0.09 0.22

PSYC Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Dec14 Mar15 Jun15 Sep15 Mar16 Jun16 Sep16 Dec16 Jun17
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.12 0.20 0.22 0.24

PSYC Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $0.24 Mil mean?
PSYC (PSYC) has a Total Receivables of $0.24 Mil as of Jun. 2017. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on PSYC and its competitors.
Is PSYC's Total Receivables too high?
PSYC's current Total Receivables is $0.24 Mil.
How does PSYC's Total Receivables compare to ARLO and TAQR?
PSYC's Total Receivables of $0.24 Mil can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Media - Diversified company?
A good Total Receivables depends on the Media - Diversified industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on PSYC and its competitors. PSYC's current Total Receivables is $0.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PSYC stock overvalued right now?
PSYC (PSYC) has a current Total Receivables of $0.24 Mil. The current Total Receivables is $0.24 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For PSYC (PSYC), the current Total Receivables is $0.24 Mil as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PSYC Business Description

Address 2881 South Valley View Boulevard, Suite 9, Las Vegas, NV, USA, 89102
PSYC Corp is a media-focused company serving the expanding industry and community of medicinal psychedelics. Through its media platform, Psychedelic Spotlight, the company has positioned itself right at the very core. These platforms provide the Company with an opportunity to dominate the intersection of cannabis and psychedelics as a media leader. Along with its subsidiary, the group offers public relations and media-focused services to companies within the medicinal psychedelics industry and other niche industries that include cannabis, holistic health, mining and precious metals, and others.